Newly added drugs in national reimbursement drug list (annual)
Total count of new drug varieties incorporated into a national reimbursement drug list during a catalog adjustment cycle.
Unit Count Industry Pharmaceuticals
The chart
Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Newly added drugs in national reimbursement drug list (annual)
China, 2024 to 2025
Every record
All records
2 records · 1 region · 2024–2025
| Period | Value | Source | Type |
|---|---|---|---|
| China 2 records | |||
| 2025 | 114 | NHSA · 31 Dec 2025 | actual |
| 2024 | 91 | State Council · 31 Dec 2024 | actual |
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2025年版国家基本医疗保险、生育保险和工伤保险药品目录和商业健康保险创新药品目录 | NHSA | — | 1 |
| 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网 | State Council | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Newly added drugs in national reimbursement drug list (annual). Retrieved from https://statorigin.org/indicators/newly-added-drugs-in-national-reimbursement-drug-list-annual